Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tangzu Granule is a Traditional Chinese Medicine (TCM) formulation developed by the Hospital of Chengdu University of TCM for the prevention and treatment of high-risk diabetic foot in patients with type 2 diabetes mellitus. The medication is designed for dual administration, involving both oral intake and external (topical) application. It aims to provide a multi-targeted therapeutic approach to manage the complications of diabetic foot, focusing on improving local microcirculation and supporting wound healing. As a hospital-developed preparation, it is currently undergoing clinical evaluation to establish a standardized evidence base for its efficacy and safety in managing diabetic complications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tangzu Granule.